News
Zeposia Approved for Moderately to Severely Active Ulcerative Colitis
The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.
Your search for oral corticosteroids returned 2 results
AAO-HNS 2021
Physician, Patient Perspectives on Successful Chronic Rhinosinusitis Management
In their presentation, Ahmad R. Sedaghat, MD, PhD and Stacey T. Gray, MD, FACS discuss both patient and physician perspectives for successful control of CRS.
